Wolfgang Janni
Universität Ulm · 1,292 works · 31,756 citations · h-index 72
Top works
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
- Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
- Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
- Association analysis identifies 65 new breast cancer risk loci
- Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
- Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
- AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020
- Treatment of Early Breast Cancer
- Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
- A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer